Dr. Hadiyah-Nicole Green, an American medical physicist, has pioneered a treatment involving laser-activated nanoparticles. In preclinical studies, her method successfully eradicated cancer in mice after a single 10-minute treatment over 15 days, with no observable side effects. This approach uses nanoparticles to target cancer cells specifically, minimizing damage to healthy tissue. To advance this research toward human clinical trials, Dr. Green founded the Ora Lee Smith Cancer Research Foundation. Advancements in Nanoparticle-Based Cancer Treatments. Beyond Dr. Green's work, other researchers are exploring nanoparticle applications in cancer therapy: Gold Nanoparticles: Researchers at MD Anderson Cancer Center are developing methods to create gold nanoparticles within tumor tissues. These particles can enhance the effectiveness of radiation therapy by increasing the radiation dose delivered directly to cancer cells, thereby sparing surrounding healthy tissue. Nanomedicine for Chemotherapy Delivery: Scientists at the University of Chicago Medicine Comprehensive Cancer Center have developed a nanomedicine approach that improves the delivery and accumulation of chemotherapy drugs in tumor tissues. In mouse models, this method effectively targeted cancer cells, potentially reducing side effects associated with traditional While these developments are promising, it's important to note that most nanoparticle-based treatments are still in the research or clinical trial stages. Extensive testing and regulatory approvals are necessary before such treatments become widely available in clinical practice.